-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] Recently, Jianzhijia, which has more than 3,000 stores, plans to acquire 100% equity of Tangren Pharmaceutical for 074 billion yuan, and the news that the latter 659 directly-operated stores will be included under its command has attracted the attention of the indust.
You must know that Jianzhijia only landed in the capital market at the end of 2020, and then aggressively acquired companies that hold pharmaceutical retail stores and the related assets and businesses of many pharmaci.
After the completion of this large-scale transaction, the number of Jianzhijia stores will increase to 3,80 There are about 3,500 pharmaceutical retail stor.
It is foreseeable that Jianzhijia will build a certain competitiveness in the Tang and Qin regions and the 6 cities in Liaoning Provin.
From the perspective of the general background, the current pattern of the entire pharmaceutical retail industry has chang.
M&A expansion has become an important way for leading companies to develop upwa.
The mergers and acquisitions of "big eats", "big eats" and even "big eats" are accelerati.
Chain pharmacies are about to enter the "Era of Ten Thousand Store.
On June 26, the People's Pharmacy announced the opening of its 10,000th store, which is also the first private listed pharmacy chain company in China with more than 10,000 stor.
As of the end of March this year, the common people had 8,612 stores, which means that in less than three months, the common people had added 1,388 stor.
In addition to the common people, according to the development momentum, Dashenlin, Yifeng Pharmacy, Yixintang, e.
are also very likely to achieve the goal of 10,000 stores this ye.
As of the end of March this year, Yifeng Pharmacy had 8,225 stores (a net increase of 416 stores in the first quarter), 8,469 Dashenlin stores (a net increase of 276 stores in the first quarter), and 8,809 Yixintang directly-operated chain stores (a net increase of 276 stores in the first quarte.
Net addition of 249 stores in the quarte.
In recent years, with the acceleration of mergers and acquisitions by leading companies and the accelerated withdrawal of small and medium-sized pharmacies, the chain rate of pharmacies across the country is accelerati.
According to the data of the State Food and Drug Administration, the chain rate of pharmacies nationwide in 2021 is 517%, a significant increase compared with 367% in 201From the perspective of policy direction, it has also become a trend to accelerate the integration and increase the chain ra.
The "Guiding Opinions on Promoting the High-Quality Development of the Drug Circulation Industry During the "14th Five-Year Plan" Period" pointed out that by 2025, 5-10 specialized pharmacies with a value of over 50 billion yuan will be cultivated, and the annual sales of the top 100 drug retail enterprises will account for The total retail market is more than 65%; the drug retail chain rate is close to 7
Up to now, the revenue of Dashenlin, Yixintang, Common People, and Yifeng has all exceeded 10 billion yuan, which is more than 5 billion yuan compared with Jianzhijia and Shuyu civilians in the evening mark.
The target is still far aw.
The chain rate of pharmacies also needs to be further improv.
It is worth mentioning that the pharmaceutical retail industry has entered an era of weak grow.
In recent years, the growth rate of net profit of chain pharmacies has slowed do.
It is reported that due to the impact of the epidemic, Dashenlin’s net profit dropped by 251% year-on-year with the expansion of 2,271 stores and an increase in operating income of 18 billion yuan in 202 This is also the first time that its net profit has declined since its listing five years a.
; Yixintang's 2022 first quarter report shows that the company's net profit fell by 317% year-on-year despite revenue grow.
The industry believes that under the trend of digital upgrading and separation of medicines, the new retail chain of pharmacies should change the original single offline sales channel and expand to the integration of online and offli.
At present, leading chain pharmacies including Yixintang, Common People, Yifeng Pharmacy, Dashenlin, Jianzhijia, Shuyu Civilian, e.
have basically completed the online channel layo.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
You must know that Jianzhijia only landed in the capital market at the end of 2020, and then aggressively acquired companies that hold pharmaceutical retail stores and the related assets and businesses of many pharmaci.
After the completion of this large-scale transaction, the number of Jianzhijia stores will increase to 3,80 There are about 3,500 pharmaceutical retail stor.
It is foreseeable that Jianzhijia will build a certain competitiveness in the Tang and Qin regions and the 6 cities in Liaoning Provin.
From the perspective of the general background, the current pattern of the entire pharmaceutical retail industry has chang.
M&A expansion has become an important way for leading companies to develop upwa.
The mergers and acquisitions of "big eats", "big eats" and even "big eats" are accelerati.
Chain pharmacies are about to enter the "Era of Ten Thousand Store.
On June 26, the People's Pharmacy announced the opening of its 10,000th store, which is also the first private listed pharmacy chain company in China with more than 10,000 stor.
As of the end of March this year, the common people had 8,612 stores, which means that in less than three months, the common people had added 1,388 stor.
In addition to the common people, according to the development momentum, Dashenlin, Yifeng Pharmacy, Yixintang, e.
are also very likely to achieve the goal of 10,000 stores this ye.
As of the end of March this year, Yifeng Pharmacy had 8,225 stores (a net increase of 416 stores in the first quarter), 8,469 Dashenlin stores (a net increase of 276 stores in the first quarter), and 8,809 Yixintang directly-operated chain stores (a net increase of 276 stores in the first quarte.
Net addition of 249 stores in the quarte.
In recent years, with the acceleration of mergers and acquisitions by leading companies and the accelerated withdrawal of small and medium-sized pharmacies, the chain rate of pharmacies across the country is accelerati.
According to the data of the State Food and Drug Administration, the chain rate of pharmacies nationwide in 2021 is 517%, a significant increase compared with 367% in 201From the perspective of policy direction, it has also become a trend to accelerate the integration and increase the chain ra.
The "Guiding Opinions on Promoting the High-Quality Development of the Drug Circulation Industry During the "14th Five-Year Plan" Period" pointed out that by 2025, 5-10 specialized pharmacies with a value of over 50 billion yuan will be cultivated, and the annual sales of the top 100 drug retail enterprises will account for The total retail market is more than 65%; the drug retail chain rate is close to 7
Up to now, the revenue of Dashenlin, Yixintang, Common People, and Yifeng has all exceeded 10 billion yuan, which is more than 5 billion yuan compared with Jianzhijia and Shuyu civilians in the evening mark.
The target is still far aw.
The chain rate of pharmacies also needs to be further improv.
It is worth mentioning that the pharmaceutical retail industry has entered an era of weak grow.
In recent years, the growth rate of net profit of chain pharmacies has slowed do.
It is reported that due to the impact of the epidemic, Dashenlin’s net profit dropped by 251% year-on-year with the expansion of 2,271 stores and an increase in operating income of 18 billion yuan in 202 This is also the first time that its net profit has declined since its listing five years a.
; Yixintang's 2022 first quarter report shows that the company's net profit fell by 317% year-on-year despite revenue grow.
The industry believes that under the trend of digital upgrading and separation of medicines, the new retail chain of pharmacies should change the original single offline sales channel and expand to the integration of online and offli.
At present, leading chain pharmacies including Yixintang, Common People, Yifeng Pharmacy, Dashenlin, Jianzhijia, Shuyu Civilian, e.
have basically completed the online channel layo.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
